These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 28463115)

  • 1. Decreased microRNA levels lead to deleterious increases in neuronal M2 muscarinic receptors in Spinal Muscular Atrophy models.
    O'Hern PJ; do Carmo G Gonçalves I; Brecht J; López Soto EJ; Simon J; Chapkis N; Lipscombe D; Kye MJ; Hart AC
    Elife; 2017 May; 6():. PubMed ID: 28463115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic modifiers ameliorate endocytic and neuromuscular defects in a model of spinal muscular atrophy.
    Walsh MB; Janzen E; Wingrove E; Hosseinibarkooie S; Muela NR; Davidow L; Dimitriadi M; Norabuena EM; Rubin LL; Wirth B; Hart AC
    BMC Biol; 2020 Sep; 18(1):127. PubMed ID: 32938453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased function of survival motor neuron protein impairs endocytic pathways.
    Dimitriadi M; Derdowski A; Kalloo G; Maginnis MS; O'Hern P; Bliska B; Sorkaç A; Nguyen KC; Cook SJ; Poulogiannis G; Atwood WJ; Hall DH; Hart AC
    Proc Natl Acad Sci U S A; 2016 Jul; 113(30):E4377-86. PubMed ID: 27402754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of smn-1, the Caenorhabditis elegans ortholog of the spinal muscular atrophy gene, results in locomotor dysfunction and reduced lifespan.
    Briese M; Esmaeili B; Fraboulet S; Burt EC; Christodoulou S; Towers PR; Davies KE; Sattelle DB
    Hum Mol Genet; 2009 Jan; 18(1):97-104. PubMed ID: 18829666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The survival motor neuron gene smn-1 interacts with the U2AF large subunit gene uaf-1 to regulate Caenorhabditis elegans lifespan and motor functions.
    Gao X; Teng Y; Luo J; Huang L; Li M; Zhang Z; Ma YC; Ma L
    RNA Biol; 2014; 11(9):1148-60. PubMed ID: 25483032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel Caenorhabditis elegans allele, smn-1(cb131), mimicking a mild form of spinal muscular atrophy, provides a convenient drug screening platform highlighting new and pre-approved compounds.
    Sleigh JN; Buckingham SD; Esmaeili B; Viswanathan M; Cuppen E; Westlund BM; Sattelle DB
    Hum Mol Genet; 2011 Jan; 20(2):245-60. PubMed ID: 20962036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival of motor neuron protein downregulates miR-9 expression in patients with spinal muscular atrophy.
    Wang LT; Chiou SS; Liao YM; Jong YJ; Hsu SH
    Kaohsiung J Med Sci; 2014 May; 30(5):229-34. PubMed ID: 24751385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defects in neuromuscular junction remodelling in the Smn(2B/-) mouse model of spinal muscular atrophy.
    Murray LM; Beauvais A; Bhanot K; Kothary R
    Neurobiol Dis; 2013 Jan; 49():57-67. PubMed ID: 22960106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HuD and the Survival Motor Neuron Protein Interact in Motoneurons and Are Essential for Motoneuron Development, Function, and mRNA Regulation.
    Hao le T; Duy PQ; An M; Talbot J; Iyer CC; Wolman M; Beattie CE
    J Neurosci; 2017 Nov; 37(48):11559-11571. PubMed ID: 29061699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancing GABAergic Transmission Improves Locomotion in a
    Wu CY; Gagnon DA; Sardin JS; Barot U; Telenson A; Arratia PE; Kalb RG
    eNeuro; 2018; 5(6):. PubMed ID: 30627660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy.
    Riessland M; Ackermann B; Förster A; Jakubik M; Hauke J; Garbes L; Fritzsche I; Mende Y; Blumcke I; Hahnen E; Wirth B
    Hum Mol Genet; 2010 Apr; 19(8):1492-506. PubMed ID: 20097677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic treatment with lithium does not improve neuromuscular phenotype in a mouse model of severe spinal muscular atrophy.
    Dachs E; Piedrafita L; Hereu M; Esquerda JE; Calderó J
    Neuroscience; 2013 Oct; 250():417-33. PubMed ID: 23876328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WDR79/TCAB1 plays a conserved role in the control of locomotion and ameliorates phenotypic defects in SMA models.
    Di Giorgio ML; Esposito A; Maccallini P; Micheli E; Bavasso F; Gallotta I; Vernì F; Feiguin F; Cacchione S; McCabe BD; Di Schiavi E; Raffa GD
    Neurobiol Dis; 2017 Sep; 105():42-50. PubMed ID: 28502804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional characterization of SMN evolution in mouse models of SMA.
    Osman EY; Bolding MR; Villalón E; Kaifer KA; Lorson ZC; Tisdale S; Hao Y; Conant GC; Pires JC; Pellizzoni L; Lorson CL
    Sci Rep; 2019 Jul; 9(1):9472. PubMed ID: 31263170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival motor neuron protein and neurite degeneration are regulated by Gemin3 in spinal muscular atrophy motoneurons.
    Miralles MP; Sansa A; Beltran M; Soler RM; Garcera A
    Front Cell Neurosci; 2022; 16():1054270. PubMed ID: 36619669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SMN regulates axonal local translation via miR-183/mTOR pathway.
    Kye MJ; Niederst ED; Wertz MH; Gonçalves Ido C; Akten B; Dover KZ; Peters M; Riessland M; Neveu P; Wirth B; Kosik KS; Sardi SP; Monani UR; Passini MA; Sahin M
    Hum Mol Genet; 2014 Dec; 23(23):6318-31. PubMed ID: 25055867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conserved genes act as modifiers of invertebrate SMN loss of function defects.
    Dimitriadi M; Sleigh JN; Walker A; Chang HC; Sen A; Kalloo G; Harris J; Barsby T; Walsh MB; Satterlee JS; Li C; Van Vactor D; Artavanis-Tsakonas S; Hart AC
    PLoS Genet; 2010 Oct; 6(10):e1001172. PubMed ID: 21124729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoration of SMN in Schwann cells reverses myelination defects and improves neuromuscular function in spinal muscular atrophy.
    Hunter G; Powis RA; Jones RA; Groen EJ; Shorrock HK; Lane FM; Zheng Y; Sherman DL; Brophy PJ; Gillingwater TH
    Hum Mol Genet; 2016 Jul; 25(13):2853-2861. PubMed ID: 27170316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased levels of UCHL1 are a compensatory response to disrupted ubiquitin homeostasis in spinal muscular atrophy and do not represent a viable therapeutic target.
    Powis RA; Mutsaers CA; Wishart TM; Hunter G; Wirth B; Gillingwater TH
    Neuropathol Appl Neurobiol; 2014 Dec; 40(7):873-87. PubMed ID: 25041530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HuD interacts with survival motor neuron protein and can rescue spinal muscular atrophy-like neuronal defects.
    Hubers L; Valderrama-Carvajal H; Laframboise J; Timbers J; Sanchez G; Côté J
    Hum Mol Genet; 2011 Feb; 20(3):553-79. PubMed ID: 21088113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.